Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 20480924)

1.

Drug Class Review: Alzheimer's Drugs: Final Report [Internet].

Hansen RA, Gartlehner G, Kaufer DJ, Lohr KN, Carey T.

Portland (OR): Oregon Health & Science University; 2006 Jun.

2.

The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.

Loveman E, Green C, Kirby J, Takeda A, Picot J, Payne E, Clegg A.

Health Technol Assess. 2006 Jan;10(1):iii-iv, ix-xi, 1-160. Review.

3.

Treatment of Alzheimer's disease in the long-term-care setting.

Smith DA.

Am J Health Syst Pharm. 2009 May 15;66(10):899-907. doi: 10.2146/ajhp070622. Review.

PMID:
19420308
4.

The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.

Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M, Hyde C.

Health Technol Assess. 2012;16(21):1-470. doi: 10.3310/hta16210. Review.

5.

Pharmacotherapeutic approaches to the treatment of Alzheimer's disease.

Standridge JB.

Clin Ther. 2004 May;26(5):615-30. Review.

PMID:
15220008
6.

Cholinesterase inhibitors for Alzheimer's disease.

Birks J.

Cochrane Database Syst Rev. 2006 Jan 25;(1):CD005593. Review.

PMID:
16437532
8.

Relative tolerability of Alzheimer's disease treatments.

Alva G, Cummings JL.

Psychiatry (Edgmont). 2008 Nov;5(11):27-36.

9.

A practical algorithm for managing Alzheimer's disease: what, when, and why?

Cummings JL, Isaacson RS, Schmitt FA, Velting DM.

Ann Clin Transl Neurol. 2015 Mar;2(3):307-23. doi: 10.1002/acn3.166. Epub 2015 Jan 23. Review.

10.

The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.

Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP.

Postgrad Med. 2005 Jan;Spec No:6-22.

PMID:
17203561
11.

Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

Nordberg A, Svensson AL.

Drug Saf. 1998 Dec;19(6):465-80. Review. Erratum in: Drug Saf 1999 Feb;20(2):146.

PMID:
9880090
12.

Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.

Tan CC, Yu JT, Wang HF, Tan MS, Meng XF, Wang C, Jiang T, Zhu XC, Tan L.

J Alzheimers Dis. 2014;41(2):615-31. doi: 10.3233/JAD-132690. Review.

PMID:
24662102
13.

Effective pharmacological management of Alzheimer's disease.

Atri A.

Am J Manag Care. 2011 Nov;17 Suppl 13:S346-55. Review.

14.

Combination therapy for Alzheimer's disease.

Patel L, Grossberg GT.

Drugs Aging. 2011 Jul 1;28(7):539-46. doi: 10.2165/11591860-000000000-00000. Review.

PMID:
21721598
15.

Contemporary issues in the treatment of Alzheimer's disease: tangible benefits of current therapies.

Tariot PN.

J Clin Psychiatry. 2006;67 Suppl 3:15-22; quiz 23. Review.

PMID:
16649847
16.
17.

Effectiveness of cholinesterase inhibitors and memantine for treating dementia: evidence review for a clinical practice guideline.

Raina P, Santaguida P, Ismaila A, Patterson C, Cowan D, Levine M, Booker L, Oremus M.

Ann Intern Med. 2008 Mar 4;148(5):379-97. Review.

PMID:
18316756
18.

Pharmacologic treatments of dementia.

Bonner LT, Peskind ER.

Med Clin North Am. 2002 May;86(3):657-74. Review.

PMID:
12171061
19.

Therapy for Alzheimer's Disease: How Effective are Current Treatments?

Lanctôt KL, Rajaram RD, Herrmann N.

Ther Adv Neurol Disord. 2009 May;2(3):163-80. doi: 10.1177/1756285609102724.

20.

Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors.

Tayeb HO, Yang HD, Price BH, Tarazi FI.

Pharmacol Ther. 2012 Apr;134(1):8-25. doi: 10.1016/j.pharmthera.2011.12.002. Epub 2011 Dec 16. Review.

PMID:
22198801
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk